About the Authors

Saar Oz

Affiliations The Adams Super Center for Brain Studies, Tel Aviv University, Tel Aviv, Israel, The Lily and Avraham Gildor Chair for the Investigation of Growth Factors, Tel Aviv University, Tel Aviv, Israel, The Elton Laboratory for Neuroendocrinology, Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Yanina Ivashko-Pachima

Affiliations The Adams Super Center for Brain Studies, Tel Aviv University, Tel Aviv, Israel, The Lily and Avraham Gildor Chair for the Investigation of Growth Factors, Tel Aviv University, Tel Aviv, Israel, The Elton Laboratory for Neuroendocrinology, Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Illana Gozes

igozes@post.tau.ac.il

Affiliations The Adams Super Center for Brain Studies, Tel Aviv University, Tel Aviv, Israel, The Lily and Avraham Gildor Chair for the Investigation of Growth Factors, Tel Aviv University, Tel Aviv, Israel, The Elton Laboratory for Neuroendocrinology, Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel

Competing Interests

Dr. Gozes serves as the Founding Scientist and a Director at Allon Therapeutics Inc., the company that develops davunetide (NAP) (www.allontherapeutics.com). This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials under required material transfer agreements.

Author Contributions

Conceived and designed the experiments: SO YIP IG. Performed the experiments: SO YIP. Analyzed the data: SO YIP IG. Contributed reagents/materials/analysis tools: IG. Wrote the paper: SO IG.